Biogen是一个生物科技公司，专注于开发创新药物，治疗各种疾病，如神经退行性疾病、自身免疫性疾病和肿瘤学等。
以下是一篇Biogen的英文范文：
Biogen is a global biotechnology company that is committed to discovering and developing innovative medicines that can transform the lives of people living with a range of diseases, including neurodegenerative conditions, autoimmune diseases, and oncology.
Our team of dedicated researchers and scientists is committed to pushing the boundaries of biotechnology to develop new and better ways to diagnose, treat, and ultimately, cure diseases. We are dedicated to working with patients, healthcare professionals, and other organizations to provide the best possible care for people living with these conditions.
Our research efforts are focused on developing new drugs that target the root causes of diseases, rather than just treating the symptoms. We are committed to developing medicines that are safer, more effective, and have a lower risk of side effects than current treatments.
At Biogen, we believe that science has the power to change lives. Our goal is to improve the quality of life for people living with a range of diseases and conditions through our research and development efforts.
希望以上信息可以帮助到您。
Biogen的意思是生物基因公司。
在英文范文当中，Biogen公司是一家全球领先的生物技术公司，专注于开发创新药物，以解决在神经科学、糖尿病和自身免疫性疾病等领域尚未满足的医疗需求。该公司是全球知名的基因疗法领导者，拥有广泛的研发平台和多元化的项目，包括临床后期项目，以治疗遗传性疾病、神经性疾病、视网膜疾病、自身免疫疾病等。该公司还致力于开发细胞疗法，以帮助加速商业化生产增长和未来扩展到其他适应症。
Biogen的意思是生物基因公司。
Biogen英文范文最新变化，具体如下^[1][2]^：
Biogen公司预计在2023年推出治疗多发性硬化症的基因疗法，利用的是经过修饰的腺相关病毒(AAV)作为药物载体，该载体的优点是组织特异性表达，安全性较高。
Biogen公司收购了Mirati公司，获得了西尼罗病毒、丙型肝炎和克罗恩病等药物的权益，向多元化的免疫和罕见病药物开发领域进一步迈进。
此外，在过去的五年里，Biogen的股价翻了三倍，从2018年的每股33.79美元到2023年的近100美元。与此同时，其收入和每股收益也增长了约三分之一，主要得益于其收购的增加和药物销售额的增长^[3]^。